Patient P-03485
Therapy response
Improving
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
53%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S14
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+24
- Inflammatory activity+12
- Nutritional resilience-8
- Treatment adherence+2
What helped?
No interventions yet.
LIFE OS recommendation
Clinician Review CR-01
80%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 100% showed improvement
- median effect visible after 5 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log6.2/10
worsening · -0.3 vs previous 14 d
Stress level
Daily log4.8/10
worsening · +0.5 vs previous 14 d
Pessimism score
Daily log3.1/10
worsening · +0.1 vs previous 14 d
Sleep quality
Wearable49.9/100
worsening · -3.5 vs previous 14 d
Libido
Daily log4.9/10
stable · +0.0 vs previous 14 d
HRV
Wearable38.4 ms
stable · -1.5 vs previous 14 d
Toxicity
Blood7.7/100
improving · -8.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 87 from the failing basin, 11 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -6.2 next day on high-intake days · n 26
- More caffeineGI -2.6 next day on high-intake days · n 25
Would not help
- Keep lactose lowGI +5 next day on high-intake days · n 15
- Keep alcohol lowGI +4.1 next day on high-intake days · n 18
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-6.2supporter · 95%
- Lactose+5detractor · 95%
- Alcohol+4.1detractor · 95%
- Caffeine-2.6supporter · 58%
- Dietary fat load+2no signal · 41%
- Histamine load+1.2no signal · 24%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.3 · butyrate capacity 61/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 40 ms
- Sleep
- 7.2 h
- Steps
- 8,620
- Resting HR
- 66 bpm
Daily log: GI score 26, nutritional resilience 64, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03008 | 49% | S16 | SC-12 | improved | 87 |
| P-03431 | 42% | S05 | DT-01 | improved | 88 |
| P-03001 | 41% | S04 | CR-01 | improved | 87 |
| P-03188 | 40% | S13 | HY-01 | improved | 79 |
| P-03288 | 40% | S15 | CR-01 | improved | 88 |
| P-03333 | 40% | S14 | SC-12 | improved | 91 |
| P-03165 | 39% | S06 | NP-02 | improved | 79 |
| P-03140 | 36% | S20 | AD-05 | improved | 79 |
| P-03018 | 34% | S05 | ME-01 | improved | 84 |
| P-03449 | 33% | S14 | DT-01 | improved | 79 |
| P-03252 | 31% | S13 | SC-12 | improved | 68 |
| P-03473 | 31% | S07 | DT-01 | improved | 70 |